If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
TREATMENT STRATEGIES
ONCOLOGY
Volume 2 Issue 1
• Breast Cancer
• Genitourinary Tumors
• Leukemia, Myelodysplasia and Transplantation
• Lung Cancer
• Lymphoma
• Neuro-oncology
• Sarcoma
Articles include:
Conventional and Novel Therapeutic Strategies in Acute
Promyelocytic Leukemia Cancer
Dynamic Risk Stratification of Prostate Cancer with Prostate-specific
Antigen Kinetics: Towards Personalized Care in Recurrent Disease
Progress in Predictive and Prognostic Biomarkers in
Gastrointestinal Cancers
Salvage Chemotherapy with Bevacizumab for Recurrent
Anaplastic Glioma
Targeting Sarcoma in 2011: Emerging Paradigms and New Treatments
Includes a review of the
ASCO 2011 Annual Meeting
SARCOMA: THE ONLY THING PROGRESSING IS THE DISEASE
THE 5-YEAR SURVIVAL RATE
IS 17% FOR PATIENTS WITH
METASTATIC SOFT TIS
TREATMENT STRATEGIES ONCOLOGY Volume 2 Issue 1 •
SARCOMA: THE ONLY THING PROGRESSING IS THE DISEAS
TREATMENT STRATEGIES Oncology Treatment Strate
NOW APPROVED Visit www.zytiga.com
CONTENTS... 3 9 10 11 18
39 43 46 49 54 60
73 77 81 84 90 93
22-25 FEBRUARY 2012 ISTANBUL, TURKEY
EDITORIALADVISORY PANEL including... Eduardo Ca
Treatment Strategies - Foreword Foreword by P
ASCOAnnual 2011Meeting Review 03 - 07 June
R1 Treatment Strategies - Congress Review www
Treatment Strategies - Congress Review disease-sp
Treatment Strategies - Congress Review Patients
Treatment Strategies - Congress Review NEW DA
Treatment Strategies - Congress Review Data P
TREATMENT STRATEGIES SERIES Visit the p
Treatment Strategies - Congress Review Novarti
Treatment Strategies - Congress Review Award High
Treatment Strategies - Congress Review continued
Treatment Strategies - Congress Review ASTELLAS P
Treatment Strategies - Congress Review Best of AS
Treatment Strategies - Congress Review Nexavar® D
CAMBRIDGERESEARCHCENTRE HEALTHC
Treatment Strategies - Congress Review New Analys
Treatment Strategies - Congress Review RES
Treatment Strategies - Congress Review Treatment
Treatment Strategies - Congress Review scientific
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review Lactofe
the Hsp90 complexes in tumor cells have a more ac
Treatment Strategies - Congress Review In anot
Treatment Strategies - Congress Review P
Treatment Strategies - Congress Review AAWD pl
Treatment Strategies - Congress Review of the
Treatment Strategies - Congress Review C
motivated or due to access issues. In the secon
Treatment Strategies - Congress Review dramati
TREATMENT STRATEGIES SERIES Visit the p
Treatment Strategies - Congress Review K
was administered orally once daily for three week
Treatment Strategies - Congress Review and eff
in several package inserts of the above-mentioned
Treatment Strategies - Congress Review AZD2171
Treatment Strategies - Congress Review P
Treatment Strategies - Congress Review
be examined on an individual patient level for th
Treatment Strategies - Congress Review New
Results Of the seven patients on study, the media
CAMBRIDGERESEARCHCENTRE HEALTHC
Treatment Strategies - Biomarkers Integrati
Treatment Strategies - Biomarkers among discov
trials and many more PoC hypotheses of equal meri
Treatment Strategies - Biomarkers data to be a
concerning the predictive biomarker based clinica
Treatment Strategies - Biomarkers Adaptive Pred
Treatment Strategies - Biomarkers a de ned com
Treatment Strategies - Biomarkers Progress
Reactivity Characteristics Score/Classi catio
Treatment Strategies - Biomarkers Study N
dMMR tumors may derive less bene t given their ov
Treatment Strategies - Biomarkers References 1
treatment for metastatic colorectal cancer (mCRC)
Treatment Strategies - Brain and Spinal Cord Canc
dependent on glutamine for survival.55 Ready acce
Treatment Strategies - Brain and Spinal Co
ant-diabetic drug metformin has been suggested as
Treatment Strategies - Brain and Spinal Cord Canc
those patients who are fragile or in poor health.
Treatment Strategies - Brain and Spinal Cord Canc
survival in GBM patients, we do not believe that
Treatment Strategies - Brain and Spinal Cord Canc
Treatment Strategies - Brain and Spinal Cord Canc
Treatment Strategies - Brain and Spinal Cord Canc
Treatment Strategies - Brain and Spinal Cord Canc
Treatment Strategies - Breast Cancer A Failur
estimation of belt e ectiveness by crash type, oc
Treatment Strategies - Breast Cancer mid-point
Treatment Strategies - Developmental Therapeutics
Treatment Strategies - Developmental Therapeutics
others) and means to prevent rapid regeneration a
Treatment Strategies - Developmental Therapeutics
Treatment Strategies - Gastrointestinal Tumors
Treatment Strategies - Gastrointestinal Tumors
Treatment Strategies - Gastrointestinal Tumors
Treatment Strategies - Genitourinary Tumors
limited value in the setting of early disease and
Treatment Strategies - Genitourinary Tumors Ref
Treatment Strategies - Genitourinary Tumors
Treatment Strategies - Genitourinary Tumors Bev
anti-VEGF monoclonal antibodies are likely restri
Treatment Strategies - Genitourinary Tumors le
Treatment Strategies - Genitourinary Tumors ca
Treatment Strategies - Gynecological Cancer
plus topotecan arm enjoyed improved median overal
Treatment Strategies - Gynecological Cancer in
and neck37,38 as well as the majority of cervical
Treatment Strategies - Gynecological Cancer el
Treatment Strategies - Gynecological Cancer Ref
Treatment Strategies - Leukemia, Myelodysplasia a
Treatment Strategies - Leukemia, Myelodysplasia a
Treatment Strategies - Leukemia, Myelodysplasia a
Treatment Strategies - Leukemia, Myelodysplasia a
Treatment Strategies - Lung Cancer Lung Can
two groups being more pronounced at the 90 day ma
Treatment Strategies - Lung Cancer treatment r
combination chemotherapy with carboplatin-paclita
Treatment Strategies - Lung Cancer References 1
Treatment Strategies - Lung Cancer Survival
Treatment Strategies - Lung Cancer Gy, convent
paclitaxel (45 mg/m) was initiated. The RT dose w
Treatment Strategies - Lung Cancer higher dose
Treatment Strategies - Melanoma See the Lig
Treatment Strategies - Melanoma forti ed foods
Treatment Strategies - Melanoma Sunbeds Overkil
Treatment Strategies - Melanoma Biophys Mol Bi
Treatment Strategies - Neuro-oncology Salva
Treatment Strategies - Neuro-oncology Author (R
Treatment Strategies - Neuro-oncology often ap
Treatment Strategies - Neuro-oncology oligoden
Treatment Strategies - New Diagnostics Role o
Treatment Strategies - New Diagnostics
Treatment Strategies - New Diagnostics
Treatment Strategies - Pediatric Oncology E
trial examined the e ect of MPH (0.6 mg/kg; 20mg
Treatment Strategies - Pediatric Oncology indu
Treatment Strategies - Pediatric Oncology diag
Treatment Strategies - Pediatric Oncology of t
Paris, France November 3–5, 2011 3rd Ann
Treatment Strategies - Sarcoma Targeting Sa
In this study by Joensuu et al. 400 patients were
Treatment Strategies - Sarcoma stable at 6 mon
Treatment Strategies - Supportive Care A Br
Treatment Strategies - Supportive Care Procedur
Treatment Strategies - Supportive Care Scale It
APOS 9TH ANNUAL CONFERENCE 23-25 FEBRUARY 2012 -
Treatment Strategies - Events Listings Upc
Treatment Strategies - Events Listings Psychos
CARFILP-3417_M01_Prelaunch_Ad_TSO_UK.indd
The Cambridge Research Centre Coppergate House 16